20 articles
A small trial found tocilizumab, an anti-inflammatory drug, cut depression remission rates better than SSRIs by targeting IL-6, not brain chemistry.
A 12-week clinical trial found older adults taking probiotics with antidepressants had greater reductions in depression and anxiety than placebo.
New research suggests AI-powered therapy may deliver better mental health outcomes than traditional human-delivered care.
Scientists used red blood cells to transport healthy mitochondria into diseased brain cells, showing promise for Parkinson's treatment.
New p-tau217 blood test forecasts Alzheimer's symptoms within 3-4 years, potentially revolutionizing early intervention strategies.
New research identifies FTL1 protein as key driver of brain aging. Reducing it restored memory and neural connections in mice.
Brown University research reveals ChatGPT and similar AI systems break 15 ethical standards when used for therapy advice.
New gene therapy zorevunersen dramatically reduced seizures in children with severe Dravet syndrome epilepsy while improving quality of life.
Scientists find that TDP43 protein regulates DNA repair systems, linking neurodegeneration to cancer when repair goes wrong.
Speed-of-processing training in adults 65+ showed lasting protection against dementia in groundbreaking 20-year study.
Early-life exposure to DEHP, a plasticizer in everyday products, caused lasting anxiety in male rats — and GABA or testosterone reversed it.
Major study identifies three existing drugs that could be repurposed to fight Alzheimer's disease, offering faster path to treatment.
Blocking the protein PTP1B boosted memory and cleared brain plaque in mice, with potential links to diabetes and obesity treatment.
Cannabis users were more likely to recall words never shown to them and struggled with everyday memory tasks in controlled experiment.
Three existing drugs, including a shingles vaccine, emerge as top candidates for repurposing against Alzheimer's disease.
A new tool that boosts mitochondrial activity in neurons restored memory in dementia mice, suggesting energy failure drives Alzheimer's symptoms.
Researchers turned ordinary brain cells into plaque-clearing machines, reducing Alzheimer's amyloid by half in mice with one treatment.
A home-based walking and resistance program improved attention and reduced observable cognitive decline in chemotherapy patients over 6 weeks.
Clinical trial shows solriamfetol significantly improves alertness and performance in workers who start before sunrise.
New brain-targeted gene therapy mimics morphine's pain relief while avoiding addiction, offering hope for 50+ million Americans with chronic pain.
